Search Results - "STALLINGS, Raymond"

Refine Results
  1. 1

    Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis by YONGXIN CHEN, STALLINGS, Raymond L

    Published in Cancer research (Chicago, Ill.) (01-02-2007)
    “…Neuroblastoma accounts for 15% of pediatric cancer deaths, and although a few protein-coding genes, such as MYCN, are involved with aggressive pathogenicity,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma by Tivnan, Amanda, Tracey, Lorraine, Buckley, Patrick G, Alcock, Leah C, Davidoff, Andrew M, Stallings, Raymond L

    Published in BMC cancer (25-01-2011)
    “…Neuroblastoma is a paediatric cancer which originates from precursor cells of the sympathetic nervous system and accounts for 15% of childhood cancer…”
    Get full text
    Journal Article
  5. 5

    Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy by Miller-Delaney, Suzanne F C, Bryan, Kenneth, Das, Sudipto, McKiernan, Ross C, Bray, Isabella M, Reynolds, James P, Gwinn, Ryder, Stallings, Raymond L, Henshall, David C

    Published in Brain (London, England : 1878) (01-03-2015)
    “…Temporal lobe epilepsy is associated with large-scale, wide-ranging changes in gene expression in the hippocampus. Epigenetic changes to DNA are attractive…”
    Get full text
    Journal Article
  6. 6

    MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2 by Foley, Niamh H, Bray, Isabella M, Tivnan, Amanda, Bryan, Kenneth, Murphy, Derek M, Buckley, Patrick G, Ryan, Jacqueline, O'Meara, Anne, O'Sullivan, Maureen, Stallings, Raymond L

    Published in Molecular cancer (21-04-2010)
    “…Neuroblastoma is a paediatric cancer of the sympathetic nervous system. The single most important genetic indicator of poor clinical outcome is amplification…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway by LYNCH, Jennifer, FAY, Joanna, MEEHAN, Maria, BRYAN, Kenneth, WATTERS, Karen M, MURPHY, Derek M, STALLINGS, Raymond L

    Published in Carcinogenesis (New York) (01-05-2012)
    “…Transforming growth factor-β (TGF-β) signaling regulates many diverse cellular activities through both canonical (SMAD-dependent) and non-canonical branches,…”
    Get full text
    Journal Article
  10. 10

    The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro by Piskareva, Olga, Harvey, Harry, Nolan, John, Conlon, Ross, Alcock, Leah, Buckley, Patrick, Dowling, Paul, Henry, Michael, O'Sullivan, Finbarr, Bray, Isabella, Stallings, Raymond L

    Published in Cancer letters (10-08-2015)
    “…Highlights • Cisplatin induced cross resistance to temozolomide, etoposide and irinotecan. • Proteomic profiling of three cisplatin resistant neuroblastoma…”
    Get full text
    Journal Article
  11. 11
  12. 12

    MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1 by Creevey, Laura, Ryan, Jacqueline, Harvey, Harry, Bray, Isabella M, Meehan, Maria, Khan, Adnan R, Stallings, Raymond L

    Published in Molecular cancer (26-03-2013)
    “…Neuroblastoma is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates…”
    Get full text
    Journal Article
  13. 13

    miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression by Oglesby, Irene K, Bray, Isabella M, Chotirmall, Sanjay H, Stallings, Raymond L, O'Neill, Shane J, McElvaney, Noel G, Greene, Catherine M

    Published in The Journal of immunology (1950) (15-02-2010)
    “…Cystic fibrosis (CF) is one of the most common lethal genetic diseases in which the role of microRNAs has yet to be explored. Predicted to be regulated by…”
    Get full text
    Journal Article
  14. 14

    miRNA Expression Profile after Status Epilepticus and Hippocampal Neuroprotection by Targeting miR-132 by Jimenez-Mateos, Eva M, Bray, Isabella, Sanz-Rodriguez, Amaya, Engel, Tobias, McKiernan, Ross C, Mouri, Genshin, Tanaka, Katsuhiro, Sano, Takanori, Saugstad, Julie A, Simon, Roger P, Stallings, Raymond L, Henshall, David C

    Published in The American journal of pathology (01-11-2011)
    “…When an otherwise harmful insult to the brain is preceded by a brief, noninjurious stimulus, the brain becomes tolerant, and the resulting damage is reduced…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Assessment of Basic Biological Functions Exerted by miRNAs by Nolan, John, Stallings, Raymond L, Piskareva, Olga

    “…Assessment of cell viability and proliferation under different miRNA expression levels is an important step in the evaluation of basic miRNA functional effects…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Metastasis suppressor microRNA-335 targets the formin family of actin nucleators by Lynch, Jennifer, Meehan, Maria H, Crean, John, Copeland, John, Stallings, Raymond L, Bray, Isabella M

    Published in PloS one (05-11-2013)
    “…MiRNAs can have pleiotropic effects by targeting multiple genes belonging to diverse signalling networks. Alternatively, miRNAs can enhance the potency of…”
    Get full text
    Journal Article